---
title: "Symplicity Spyral renal denervation system gains Japanese PMDA approval"
date: "2025-09-03T10:02:23.000Z"
publishedDate: "3 septembre 2025"
summary: "Medtronic has announced it received approval in Japan from the Pharmaceuticals and Medical Devices Agency (PMDA) for its Symplicity Spyral renal denervation system for the treatment of resistant hypertension. The company will now initiate the process to obtain approval for insurance coverage."
importance: ""
sourceUrl: "https://vascularnews.com/symplicity-spyral-renal-denervation-system-gains-japanese-pdma-approval/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-09-03-symplicity-spyral-renal-denervation-system-gains-japanese-pmda-approval"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/11/Medtronic_plc_RDN_Symplicity_Spyral_Down_Barrel_lyr.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/symplicity-spyral-renal-denervation-system-gains-japanese-pdma-approval/"
---

![Symplicity Spyral renal denervation system gains Japanese PMDA approval](https://vascularnews.com/wp-content/uploads/sites/7/2023/11/Medtronic_plc_RDN_Symplicity_Spyral_Down_Barrel_lyr.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/symplicity-spyral-renal-denervation-system-gains-japanese-pdma-approval/*

## L’essentiel

Medtronic has announced it received approval in Japan from the Pharmaceuticals and Medical Devices Agency (PMDA) for its Symplicity Spyral renal denervation system for the treatment of resistant hypertension. The company will now initiate the process to obtain approval for insurance coverage.

## Lien source

https://vascularnews.com/symplicity-spyral-renal-denervation-system-gains-japanese-pdma-approval/
